Imbalance of naive and memory T lymphocytes with sustained high cellular activation during the first year of life from uninfected children born to HIV-1-infected mothers on HAART

Imbalance of naive and memory T lymphocytes with sustained high cellular activation during the first year of life from uninfected children born to HIV-1-infected mothers on HAART

The immune consequences of in utero HIV exposure to uninfected children whose mothers were submitted to highly active antiretroviral therapy (HAART) during gestation are not well defined. We evaluated 45 HIV-exposed uninfected (ENI) neonates and 45 healthy unexposed control (CT) neonates. All HIV-in...

Full description

Bibliographic Details
Main Authors:	E. Ono, A.M. Nunes dos Santos, R.C. de Menezes Succi, D.M. Machado, D.S.A. de Angelis, R. Salomão, E.G. Kallás, M.I. de Moraes-Pinto
Format:	Article
Language:	English
Published:	Associação Brasileira de Divulgação Científica 2008-08-01
Series:	Brazilian Journal of Medical and Biological Research
Subjects:	Immunophenotyping Highly active antiretroviral therapy HIV-1 Immunological stimulation Neonates of HIV-infected mothers
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2008000800011

Similar Items

Parkinsonism and AIDS: a clinical comparative study before and after HAART
by: Ana Lucia Zuma de Rosso, et al.
Published: (2009-09-01)

NECESSITY OF AGE-RELATED STANDARDS FOR IMMUNE PHENOTYPING OF BLOOD CELLS FOR MONITORING OF HEALTH IN CHILDREN BORN BY HIV-INFECTED WOMEN
by: B. A. Bakhmetyev, et al.
Published: (2012-05-01)

Sertraline Pharmacokinetics in HIV-Infected and Uninfected Children, Adolescents, and Young Adults
by: Nathan John Hanan, et al.
Published: (2019-02-01)

Diabetes mellitus and associated risk factors among HIV infected patients on HAART
by: Lucy Kanyara, et al.
Published: (2024-03-01)

Social and immunological differences among uninfected Brazilians exposed or unexposed to human immunodeficiency virus-infected partners
by: Maria Luiza Silva, et al.
Published: (2014-09-01)

Antiretroviral therapy during pregnancy and early neonatal life: consequences for HIV-exposed, uninfected children
by: Patrícia El Beitune, et al.

Dental caries status of children receiving Highly active antiretroviral therapy (HAART) - A multicentric cross-sectional study in Tamil Nadu, India
by: G Shanmugavadivel, et al.
Published: (2020-01-01)

Neurodevelopmental assessment of HIV-exposed uninfected and early-treated HIV-infected children: study protocol
by: Renate Strehlau, et al.
Published: (2018-04-01)

Comparison of Immunological and Virological Recovery with Rapid, Early, and Late Start of Antiretroviral Treatment in Naive Plwh: Real-World Data
by: Sarıgül Yıldırım F, et al.
Published: (2023-05-01)

Blood Mitochondrial DNA Content in HIV-Exposed Uninfected Children with Autism Spectrum Disorder
by: Matthew A. Budd, et al.
Published: (2018-02-01)

Increased household exposure to respiratory pathogens in HIV exposed uninfected children due to maternal HIV
by: Tila Khan, et al.
Published: (2019-01-01)

Diagnosis, antiretroviral therapy, and emergence of resistance to antiretroviral agents in HIV-2 infection: a review
by: Maia Hightower, et al.

Use of Tenofovir Alafenamide/Emtricitabine/Elvitegravir-Cobicistat in HIV-Naive Patients with Advanced Disease: GENIS Study
by: Javier Perez Stachowski, et al.
Published: (2022-08-01)

Comparable Vδ2 Cell Functional Characteristics in Virally Suppressed People Living with HIV and Uninfected Individuals
by: Matthew L. Clohosey, et al.
Published: (2020-12-01)

HIV antiretroviral preexposure prophylaxis
by: Richard Tjan
Published: (2015-12-01)

Craniofacial morphology of HIV-infected adolescents undergoing highly active antiretroviral therapy (HAART): An original research
by: M Neeraja, et al.
Published: (2020-01-01)

Emergent dolutegravir resistance in integrase-naïve, treatment experienced patients from Zimbabwe
by: Linda A. Mandikiyana Chirimuta, et al.
Published: (2022-10-01)

Extremely low viral reservoir in treated chronically HIV-1-infected individuals
by: Cristina Gálvez, et al.
Published: (2020-07-01)

No Difference in Growth Outcomes up to 24 Months of Age by Duration of Exposure to Maternal Antiretroviral Therapy Among Children Who Are HIV-Exposed and Uninfected in Malawi
by: Gabriela Toledo, et al.
Published: (2022-06-01)

Association of beta-defensin gene copy number variation with CD4 count and viral load among Malaysian ethnics hiv patients after HAART initiation
by: Achim, Nurfarahin Hanini
Published: (2020)

Anxiety and Associated Factors Among Clients on Highly Active Antiretroviral Therapy (HAART) in Public Hospitals of Southern Ethiopia: A Multi-Center Cross-Sectional Study
by: Kechine T, et al.
Published: (2022-12-01)

One size doesn’t fit all: Tailoring adult antiretroviral treatment
by: Nathan Geffen, et al.
Published: (2014-09-01)

Ten Years HIV Free: An Interview with “The Berlin Patient,” Timothy Ray Brown
by: Michael M. Lederman, et al.
Published: (2017-11-01)

Training, guideline access and knowledge of antiretroviral interactions: Is the South African private sector being left behind?
by: BS Chisholm, et al.
Published: (2022-10-01)

Impact of antenatal antiretroviral drug exposure on the growth of children who are HIV-exposed uninfected: the national South African Prevention of Mother to Child Evaluation cohort study
by: Vundli Ramokolo, et al.
Published: (2022-12-01)

Predictive effects of body mass index on immune reconstitution among HIV-infected HAART users in China
by: Xiaolin Li, et al.
Published: (2019-05-01)

Treatment Adherence And Persistence Among HIV-1 Patients Newly Starting Treatment
by: Hines DM, et al.
Published: (2019-11-01)

Penggunaan Highly Active Antiretroviral Theraphy (HAART) Terhadap Health Related Quality of Life (HRQOL) pada Orang Dengan HIV/AIDS
by: Angga Wilandika
Published: (2018-12-01)

Incidence of Bacteremia in Antiretroviral-naive HIV-positive Children Less Than Five Years of Age in Benin City-Nigeria
by: Imade PE, et al.
Published: (2010-01-01)

Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients
by: Tony Antoniou, et al.
Published: (2017-04-01)

Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults
by: Sharlene Ho, et al.
Published: (2020-05-01)

Determinants of Virological Failure in HIV Patients on Highly Active Antiretroviral Therapy (HAART): A Retrospective Cross-Sectional Study in the Upper East Region of Ghana
by: Abdulai Abubakari, et al.
Published: (2023-01-01)

Magnitude and correlates of moderate to severe anemia among adult HIV patients receiving first line HAART in Northwestern Tanzania: a cross sectional clinic based study
by: Daniel Wilfred Gunda, et al.
Published: (2016-02-01)

Closing the gaps: Steps towards elimination of mother-to-child transmission of HIV
by: Mary Ibeto, et al.
Published: (2014-09-01)

Treatment of AIDS-related thrombocytopenia: a case report
by: Abdi Z, et al.
Published: (2012-05-01)

Studying the Causes of Virologic Failure in the Early Stages of Antiretroviral Therapy in HIV-Infected Patients
by: M.H. Liulchuk
Published: (2015-02-01)

Maternal ART throughout gestation prevents caudate volume reductions in neonates who are HIV exposed but uninfected
by: Abdulmumin Ibrahim, et al.
Published: (2023-03-01)

Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes?
by: Catherine Orrell, et al.
Published: (2017-04-01)

Stavudine dosage reduction: Effect on symptomatic hyperlactataemia and lactic acidosis in patients at Dr George Mukhari Hospital, Pretoria
by: M Nlooto, et al.
Published: (2013-02-01)

Willingness to pay for treatment with highly active antiretroviral (HAART) drugs: a rural case study in Cameroon
by: Kenneth Ngwambokong Muko, et al.
Published: (2004-08-01)